Could a common Alzheimer's drug sharpen thinking in schizophrenia?
NCT ID NCT04857983
First seen Feb 13, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This study looked at whether adding the drug memantine to a computer-based cognitive training program could improve thinking skills and daily function in people with schizophrenia or schizoaffective disorder. 62 adults took part in a double-blind trial where some received memantine and others a placebo alongside the training. The goal was to see if memantine could enhance the brain's ability to learn and lead to better real-world outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Teaching Facility (CTF B-403 at UCSD Medical Center)
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.